----

|   | Telephone: | +61      (0)3 8686 6573 |
|--------|------------|-------------------------|

|   | Email: | bernard.oshea@deacons.com.au |
|--------|--------|------------------------------|

|   | Website: | www.deacons.com.au |
|--------|----------|--------------------|

|   | Our      ref: | 2626784 |
|--------|---------------|---------|

----

| Contents                                  |                                                             |   |
|-------------------------------------------|------------------------------------------------------------------|--------|
|                                      |                                                             |   |
| 1.                                        | Definitions      and interpretation                              | 1      |
| 2.                                        | Development      of the First Product                            | 6      |
| 3.                                        | Supply      of Products                                          | 6      |
| 4.                                        | Price                                                            | 13     |
| 5.                                        | Development      of New Products                                 | 14     |
| 6.                                        | OcuSense      Licence                                            | 18     |
| 7.                                        | Obligations      of MiniFAB                                      | 20     |
| 8.                                        | Meeting                                                          | 20     |
| 9.                                        | Payment      and invoicing                                       | 21     |
| 10.                                       | Amendments      to Specifications                                | 21     |
| 11.                                       | Registrations,      safety and Product liability                 | 22     |
| 12.                                       | Insurance                                                        | 23     |
| 13.                                       | Warranties                                                       | 23     |
| 14.                                       | Third      party licensors and contractors; Technology Transfer. | 23     |
| 15.                                       | Term,      breach and termination                                | 26     |
| 16.                                       | Liability      and indemnity                                     | 27     |
| 17.                                       | Goods      and services tax                                      | 29     |
| 18.                                       | Confidentiality                                                  | 29     |
| 19.                                       | Disputes                                                         | 31     |
| 20.                                       | Force      Majeure                                               | 33     |
| 21.                                       | Notices                                                          | 33     |
| 22.                                       | General                                                          | 34     |
| Schedule      1 First Product             | 36                                                               |
| Schedule      2 Form of Development Order | 37                                                               |

----

|  | Parties | MiniFAB (Aust) Pty Ltd      ACN 100 768 474 |
|--|---------|---------------------------------------------|

|   | A. | MiniFAB      is a micro-nano-bio company that offers customised manufacturing      and advanced product developmentservices. |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------|

|   | B. | OcuSense      is an in-vitro diagnostics company that is developing and desires to      commercialise a proprietary tear testing platform, TearLabTM, capable of      accurately and rapidly diagnosing various eye diseases at the      point-of-care. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | C. | MiniFAB      and OcuSense are parties to that certain development agreement for a tear      collection interface (“TCI”) device comprised of      Terms of Business and the Project Proposal for Project Tear-Sense (Stage      0), each dated 17 November 2006 (collectively, the "Development      Agreement"). |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | D. | OcuSense      wishes to acquire the services of MiniFAB in the manufacture and      supply  of the TCI Device developed under the Development      Agreement, as well as potential development and manufacture of other TCI      Devices, and MiniFAB has agreed to provide such services, on the terms of      this Agreement. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 1. | Definitions      and interpretation |
|--|----|-------------------------------------|

|  | 1.1  | Definitions |
|--|-----------|-------------|

|   | (1) | Agreement means this      document, including any schedule or annexure to  it; |
|--------|-----|--------------------------------------------------------------------------------|

|   | (2) | Annual Production      Capacity means, in respect of each Product, the      quantity |
|--------|-----|--------------------------------------------------------------------------------------|

|   | of      the Product that MiniFAB is reasonably capable of manufacturing each year,      and as varied in accordance with clause 3.5. The Annual Production      Capacity for the First Product is specified in Schedule 1 and the Annual      Production Capacity for the New Products is to be agreed between the      parties pursuant to clause 5.8; |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (3) | Business Day means a day      that is not a Saturday, Sunday or any other day which is a public holiday      or a bank holiday in Melbourne,Australia; |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (4) | cGMP means current Good      Manufacturing Practices, as established by  the FDA; |
|--------|-----|----------------------------------------------------------------------------------------|

|   | (5) | Commencement Date means      October 19, 2007; |
|--------|-----|------------------------------------------------|

----

|   | (6) | Commercially Reasonable      Efforts means the exercise of such efforts and commitment of      such resources by MiniFAB as would be expended on, or committed by MiniFAB      for, a comparable development or manufacturing program of a similar scope      and at a similar stage in development or product lifecycle, comparable      profit margin and potential, competitive landscape, and risk profile, in      each case with due regard to the nature of efforts and cost required for      such development or manufacturing and taking into account payments made by      OcuSense, or obligated to be made by OcuSense, under this      Agreement; |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (7) | Confidential Information      of a party means any Information (and all tangible and intangible      embodiments thereof of any kind whatsoever) provided by that party or its      Representatives to the other party or its Representatives whether provided      orally or in any form and is marked, identified as or otherwise      acknowledged to be confidential at the time of disclosure to the other      party; provided, however, that information, data and results generated by      MiniFAB under the Development Agreement, or in the course of performing      activities under this Agreement, that relate to OcuSense's technology or      to the development of Products or prototypes thereof shall be deemed the      Confidential Information ofOcuSense; |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (8) | Default Rate means 10%      per annum; |
|--------|-----|----------------------------------------|

|   | (9) | Delivery Point means the      premises of MiniFAB located at 1 Dalmore Drive, Scoresby, Victoria,      AUSTRALIA; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------|

|   | (10) | Development Expenses      means all costs and expenses incurred by MiniFAB for the development      of a New Product as more particularly described in clause 5.5(1)(a),      but does not include the capital expenditures referred to in clause 5.5(1)(b); |
|--------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (11) | Development Order means      a document substantially in the form set out in Schedule 2 executed      by or on behalf of MiniFAB and OcuSense which details a New Product      to be developed by MiniFAB in accordance with clause  5; |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (12) | Development Request has      the meaning given in clause 5.2; |
|--------|------|---------------------------------------------------------------|

|   | (13) | EXW means "ex works",      according to the Incoterms 2000 published by the International      Chamber of Commerce (ICC) as amended from time to  time; |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (14) | FDA means the United      States Food and DrugAdministration; |
|--------|------|---------------------------------------------------------------|

|   | (15) | First Product means the      TCI Device developed under the Development Agreement, together with      the capsule and applicable packaging, all as further described in Schedule      1; |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (16) | Force Majeure means any      cause which is not within the reasonable control of the party affected by      it including, but not limited to, acts of God, war declared or undeclared,      civil disturbance, acts or omissions of government or other competent      authority, fire, lightning, explosion or flood, but excludes any cause due      to lack of demand or market success for the  Products; |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (17) | Governmental Agency      means any court, administrative agency or commission or other      governmental agency, body or instrumentality, domestic or      foreign; |
|--------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (18) | Information means any      information or know-how pertaining to, or in the possession or      control of, a party including, but not limited to,      information concerning its business, systems, technology and afairs,      such as: |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | (a) | financial,      technological, strategic or business information, concepts, plans,      strategies, directions orsystems; |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------|

|   | (b) | research,      development, operational, legal, marketing or accounting information,      concepts, plans, strategies, directions or  systems; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | technology,      source and object codes for computer sofware, intellectual property      rights and technical and historical information relating      thereto; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (d) | customer      and supplier information; and |
|--------|-----|---------------------------------------------|

|   | (e) | information      relating to the Products; |
|--------|-----|--------------------------------------------|

|   | (19) | Insolvency Event in the      context of a person means: |
|--------|------|---------------------------------------------------------|

|   | (a) | a      receiver, receiver and manager, official manager,      trustee, administrator, other controller (as defined in the Corporations Act      2001 (Cth)) or similar official is appointed, or steps are      taken for such appointment, over any of the equipment or undertaking      of the person; |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | the      person is or becomes unable to pay its debts when they are due or is      or becomes unable to pay its debts within the meaning of the Corporations Act      2001 (Cth) or is presumed to be insolvent under the Corporations Act      2001 (Cth); |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | the      person ceases or threatens to cease to carry on business;    or |
|--------|-----|--------------------------------------------------------------------------|

|   | (d) | an      application or order is made for the liquidation of the person or a resolution      is passed or any steps are taken to liquidate or pass a resolution for the      liquidation of the person otherwise than for the purpose of an      amalgamation orreconstruction; |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (20) | Intellectual Property      means any copyright, design (whether registered or unregistered),      trademark (whether registered or unregistered), patent or patent      application or invention, circuit layout, know-how, confidential      information (whether such information is in writing or recorded in any      other form) and other proprietary or personal rights arising from      intellectual activity in the business, industrial, scientific or artistic      fields; |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (21) | Supply Start Date has      the meaning given in clause 3.2(2); |
|--------|------|----------------------------------------------------------------|

|   | (22) | Loss means any loss,      damage, cost, interest, expense, fee, penalty, fine, forfeiture,      assessment, demand, liability or damages incurred by a person to the      extent resulting from any action, suit, claim, proceeding or cause of      action brought against such party by a third  party. |
|--------|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (23) | Minimum Orders means, in      respect of each Product, the minimum quantity of Product that      OcuSense must purchase from MiniFAB during a specified period. The      Minimum Orders are specified in clause3.3(7); |
|--------|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (24) | New Products means any      TCI Devices developed pursuant to this Agreement and any other goods      that the parties agree are New Products. For the avoidance of doubt,      New Products do not include the FirstProduct; |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (25) | OcuSense IP has the meaning      given in clause 6.1; |
|--------|------|-----------------------------------------------------------------|

|   | (26) | Price means, in respect      of each Product, the price payable by OcuSense to MiniFAB for the      supply of that Product, inclusive of all packaging, labelling and all      other handling charges (other than the freight  costs); |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (27) | Products means the First      Product and any New Products; |
|--------|------|-------------------------------------------------------------|

|   | (28) | Prototype First Product      means a pre-production prototype of the First Product conforming to      the First Product Requirement Definitions, and mayinclude prototype units      of the First Product at different stages of development (such      as, for example, alpha prototypes and beta    prototypes). |
|--------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | (29) | Purchase Order has the      meaning given in clause 3.4; |
|--------|------|----------------------------------------------------------|

|   | (30) | Quarter means a period      of three months commencing on 1 January, 1 April, 1 July or 1      October; |
|--------|------|--------------------------------------------------------------------------------------------------------------|

|   | (31) | R&D Services means      those development services for New Products as specified in clause      5.1; |
|--------|------|---------------------------------------------------------------------------------------------------------------|

|   | (32) | Registrations means all      registrations or approvals required from the relevant Regulatory      Authority or Authorities for the export, import, storage,      promotion, supply, sale or other distribution in the of the      Products; |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (33) | Regulatory Authority      means any Governmental Agency having responsibility for the      regulation of, oversight of or whose approval is required for      the manufacture, marketing, sale or supply of the Products or the      facilities in which it ismanufactured; |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (34)  | Regulatory Requirements      means, collectively: |
|--|------------|---------------------------------------------------|

|  | (a) | all      laws and regulations and any and all other requirements of the FDA or      any other Regulatory Authority that are mandatory to the manufacture,      packaging, labelling, storage, handling and shipment of the Products by      MiniFAB and, subject to clause 2.1, includes cGMP;  and |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (b) | all      standards set by the International Organization for Standardization (ISO)      that are mandatory to the manufacture, packaging, labelling, storage,      handling and shipment of the Products by MiniFAB, including without      limitation ISO 13485:2003 (Medical Devices Quality Management System), ISO      10993-1 (Biocompatibility), ISO 10993-5 (Biocompatibility: Cytotoxicity),      and ISO 10993-10 (Biocompatibility: Sensitization and Irritation), but      excludes |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (c) | any      law, regulation, requirement or standards that apply to the design,      trials, marketing, sales or supply of the Products (and which do not also      apply to the manufacture of Products and/or to MiniFAB's supply to      OcuSense hereunder); |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (35) | Representative of a      party means the employees, directors, agents or advisors of that      party; |
|--------|------|------------------------------------------------------------------------------------------------------------|

|   | (36) | Requirement Definitions      means, with respect to any Product, the written documentation guiding      MiniFAB's development of such Product, including detailed requirement      definitions for such Product, as agreed by the parties. The initial      Requirement Definitions for the First Product have been agreed by the      parties as of the Commencement Date. The Requirement Definitions may be      modified from time to time by mutual agreement of OcuSense and MiniFAB in      the course of development work for such Product, and MiniFAB agrees to use      Commercially Reasonable Efforts to accommodate changes to the Requirement      Definitions as OcuSense may from time to time  request; |
|--------|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (37) | Second Product means the      first New Product developed pursuant to this Agreement, which the parties      intend to be a TCI Device similar to the First Product, provided that such      product would be designed to measure either (i) a marker other than      osmolarity, or (ii) both osmolarity and one other additional      marker; |
|--------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | (38) | Specifications means,      with respect to any Product, the definitive written documentation      guiding MiniFAB's manufacture, packaging, labelling, storage and handling      of such Product, prepared and agreed in accordance with clause 3.1; in      each case, and as modified from time to time by mutual agreement of      OcuSense and MiniFAB in accordance with clause  10; |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (39) | Successful Completion      has the meaning provided in clause5.10; |
|--------|------|--------------------------------------------------------------------|

|   | (40) | TCI Device means any tear      collection interface device or any microfluidicbased    device; |
|--------|------|------------------------------------------------------------------------------------------------|

|   | (41) | Technical Agreement      means the technical agreement entered into between MiniFAB and OcuSense      with respect to each Product, as may be amended from time to time, which      specifies their respective responsibilities for quality control and      quality assurance and related activities and qualifications with respect      to the applicable Product. The Technical Agreement for the First Product      shall be entered into concurrently with this Agreement. Mutually agreed      Technical Agreements for other Products shall be entered into prior to      commercial manufacture and supply of such  Products; |
|--------|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (42) | Term means the term of      this Agreement, including any extended term underclause 15.1;      and |
|--------|------|----------------------------------------------------------------------------------------------------|

|   | (43) | Wholesale Price of a      Product at a particular time means the highest wholesale price at      which OcuSense has sold such Product to third parties during the      previous 3 months period. |
|--------|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1.2 | Interpretation |
|--------|-----|----------------|

|   | (1) | Reference      to: |
|--------|-----|--------------------|

|  | (a) | one      gender includes the others; |
|--|-----|--------------------------------------|

|  | (b) | a      person includes a body corporate; |
|--|-----|------------------------------------------|

|  | (c) | a      party includes the party's executors, administrators, successors      and permitted assigns; |
|--|-----|----------------------------------------------------------------------------------------------------------|

|  | (d) | a      statute, regulation, code or other law or a provision of any of      them includes: |
|--|-----|-------------------------------------------------------------------------------------------------|

|  | (i) | any      amendment or replacement of it; and |
|--|-----|----------------------------------------------|

|  | (ii) | another      regulation or other statutory instrument made under it, or      made under it as amended or replaced;and |
|--|------|-----------------------------------------------------------------------------------------------------------------------|

|   | (e) | dollars      means Australian dollars unless otherwise  stated. |
|--------|-----|-----------------------------------------------------------------|

|  | (2) | "Including"      and similar expressions are not words of  limitation. |
|--|-----|------------------------------------------------------------------------|

|  | (3) | Where      a capitalized word or expression is given a particular meaning,      other parts of speech and grammatical forms of that capitalized word      or expression have a correspondingmeaning. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | Headings      and any table of contents or index are for convenience only and do not      form part of this Agreement or affect its  interpretation. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | A      provision of this Agreement must not be construed to the disadvantage of a      party merely because that party was responsible for the preparation of the      Agreement or the inclusion of the provision in the    Agreement. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | If      an act must be done on a specified day which is not a Business Day, it      must be done instead on the next Business  Day. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 1.3 | Parties |
|--|-----|---------|

|   | (1) | If      a party consists of more than 1 person, this Agreement binds each of      them separately and any 2 or more of them  jointly. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | An      obligation, representation or warranty in favour of more than 1 person is      for the benefit of them separately and  jointly. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------|

|   | (3) | A      party which is a trustee is bound both personally and in its capacity as      a trustee. |
|--------|-----|------------------------------------------------------------------------------------------------------|

|  | 2. | Development      of the First Product |
|--|----|---------------------------------------|

|  | 2.1 | Regulatory approvals and      exemptions |
|--|-----|------------------------------------------|

|  | 2.2 | Design Development      completed |
|--|-----|-----------------------------------|

|  | 2.3  | Prototype Acceptance      Testing |
|--|-----------|-----------------------------------|

|  | (1) | The      parties agree that MiniFAB has manufactured and supplied to OcuSense      sufficient units of the Alpha Prototype First Product for the purposes of      testing on or about 26 July 2007, and that prior to the Commencement Date,      OcuSense has tested such units to determine whether the Alpha Prototype      First Product is as described in "Design Specification Stage 1 Work      package |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | The      parties acknowledge that, as of the Commencement Date, manufacture, supply      and testing of units of the Beta Prototype First Product has not yet      occurred, and further acknowledge that the terms and conditions of the      Development Agreement continue to apply with respect to such      activities. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | MiniFAB      will, in accordance with its obligations under the      Development Agreement, develop and optimise its manufacturing process      such that MiniFAB can manufacture the First Product to meet the      Minimum Orders of the FirstProduct. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 3. | Supply      of Products |
|--|----|-------------------------|

|  | 3.1 | Specifications |
|--|-----|----------------|

|  | (1) | The      initial Specifications for the First Product have been agreed by the      parties prior to execution of this Agreement. Promptly after      OcuSense's Acceptance of a New Product as set forth in clause 5.9, MiniFAB      shall prepare, on the basis of the most recent Requirement Definitions for      such New Product, and provide to OcuSense for approval, the definitive      Specifications for the applicable Product, for MiniFAB's use to      manufacture, package, label, store and handle the applicable      Product. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | (2) | OcuSense      will review the Specifications submitted by MiniFAB under      clause 3.1(1) and may request amendments or modifications to the      Specifications if: |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | the      Specifications are inconsistent with the Requirement      Definitions; |
|--------|-----|---------------------------------------------------------------------------------|

|  | (b) | the      Specifications are inconsistent with the Regulatory      Requirements; |
|--|-----|---------------------------------------------------------------------------------|

|  | (c) | the      requirements of the Specifications are unreasonable or uncommercial      having regard to the Price or proposed Price of the relevant Product;      or |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (d) | the      requirements of the Specifications are unrelated to the      Product. |
|--|-----|--------------------------------------------------------------------------------|

|   | (3) | MiniFAB      must act reasonably and accommodate any requests for amendment to the      Specifications made by OcuSense under clause  3.1(2). |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (4) | OcuSense      must accept the Specifications when it is satisfied that the      Specifications are consistent with the Requirement Definitions and the      Regulatory Requirements, and are reasonable and commercial having regard      to the Price or proposed Price of the relevant  Product. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (5) | The      parties agree that the definitive Specifications for the First Product are      set forth in Annexure B. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------|

|   | (6) | The      Specifications for any Product may be modified or amended by mutual      written agreement of the Parties. In the event that OcuSense requests      changes to the Specifications for reasons other than those set forth in      clause 3.1(2) above, MiniFAB agrees to use Commercially Reasonable Efforts      to accommodate such requestedchanges. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 3.2 | Capital investments and Supply      Start Date |
|--|-----|------------------------------------------------|

|  | (1)  | MiniFAB      will: |
|--|-----------|--------------------|

|   | (a) | in      respect of the First Product - from the Commencement Date;    and |
|--------|-----|---------------------------------------------------------------------------|

|   | (b) | in      respect of each New Product - in accordance with the project      plan specified in the Development Order for that New      Product, |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | MiniFAB      will notify OcuSense when MiniFAB reasonably believes that it has the      necessary plant and equipment to manufacture a particular Product to meet      the Minimum Orders of that Product. Promptly following such notification      by MiniFAB, the parties shall mutually agree on and set the date (Supply Start Date for      that Product) on which OcuSense may begin placing binding Purchase Orders      for that Product pursuant to clause3.4. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (3) | It      is the intention of the parties that the Supply Start Date for the First      Product shall take place no later than March 15, 2008 (the initial "Cut-Off Date"). If the      Supply Start Date for the First Product has not taken place on or prior to      the Cut-Off Date, then, provided that MiniFAB has used Commercially      Reasonable Efforts to meet the Cut-Off Date, the parties    will: |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | meet      and discuss the reasons for thefailure; |
|--------|-----|---------------------------------------------------|

----

|  | (b) | negotiate      a mutually agreed remedy plan to address the reasons for the failure;      and |
|--|-----|----------------------------------------------------------------------------------------------------|

|  | (c) | acting      reasonably, agree on a revised Cut-Off Date, subject to clause 3.2(4)      . |
|--|-----|------------------------------------------------------------------------------------------|

|   | (4) | The      procedures described in clause 3.2(3) will apply for at least two times,      but the revised Cut-Off Date shall not be later than sixty (60) days      following the initial Cut-Off Date specified in clause 3.2(3), above. If      MiniFAB fails to meet the Cut-Off Date for the third time, then OcuSense      may immediately terminate this Agreement, which shall be effective upon      written notice to MiniFAB. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 3.3  | Supply and Purchase      Obligations |
|--|-----------|--------------------------------------|

|   | (1) | MiniFAB      shall manufacture the Products exclusively for OcuSense; and MiniFAB      shall sell the Products exclusively to OcuSense or its designee; and      MiniFAB shall not otherwise manufacture, sell, or distribute the Products      to any third party. MiniFAB acknowledges that OcuSense may manufacture      Products itself and/or engage one or more third parties in addition to      MiniFAB to supply the Products toOcuSense. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | (4) | MiniFAB      hereby acknowledges that OcuSense needs to obtain a reliable supply of the      Products that meets certain quality, quantity and timing requirements, and      agrees to comply with the following Supply      Requirements: |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (a) | subject      to clause 3.2(3), ensure that the Supply Start Date for the First Product      occurs on or prior to the Cut-OffDate; |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------|

|  | (b) | ensure      that the Supply Start Date for the Second Product occurs on or prior to      the applicable cut-off date as specified in the Development Order for the      Second Product; |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (c) | ensure      that each batch of Product are in full compliance with the Specifications      (including without limitation any failure rates specified therein), the      Technical Agreement, and the Regulatory Requirements;  and |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (d) | ensure      that, for each 3 month period, at least 95% of shipments of Products are      delivered by the delivery date required under clause  3.6. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (5) | If      MiniFAB fails to comply with the Supply Requirements then, subject      to clause 3.3(6): |
|--------|-----|--------------------------------------------------------------------------------------------------------|

|  | (a) | MiniFAB      must provide OcuSense with the reasons for      the non-compliance; |
|--|-----|---------------------------------------------------------------------------------------|

|  | (b) | the      parties must meet and discuss the reasons given by  MiniFAB; |
|--|-----|-----------------------------------------------------------------------|

|  | (c) | the      parties must, acting reasonably, negotiate a mutually agreed remedy      plan to address the reasons for the non-compliance;  and |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (d) | MiniFAB      must implement the agreed remedyplan. |
|--|-----|----------------------------------------------------|

|  | (6) | If      MiniFAB fails to comply with the same Supply Requirement again within      a period of 3 months after the first non-compliance, then MiniFAB is      deemed to have committed a material breach of this Agreement for the      purposes of clause 15.2(1). |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (9) | OcuSense      shall have no purchase obligations under this Agreement, except as      expressly set forth in this clause 3.3. For the avoidance of doubt,      subject to clauses 3.3(2), 3.3(7) and 3.3(8), OcuSense shall have the      right to engage any third party to manufacture and supply any      Products. |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 3.4 | Forecast and      ordering |
|--|-----|----------------------------|

|   | (1) | Not      less than 3 months prior to the Supply Start Date for a Product and on      or before the 1st date of each calendar month thereafter, OcuSense      must submit to MiniFAB a non-binding forecast of the quantity of each of      the Products that OcuSense expects to purchase in each of the 3rd through      the 6th month following the month for which the forecast is due (e.g., the      forecast due on January 1, 2010 would contain a forecast for April through      June of 2010). |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | OcuSense      must order the Products 45 days prior to their requested deliverydates (as      determined in accordance with clause 3.6) by sending binding written      purchase orders to MiniFAB stating the Product, unit quantities and any      other information reasonably required by MiniFAB from time to time (Purchase Orders).      OcuSense may begin placing Purchase Orders for any particular Product      commencing with the Supply Start Date for that Product. OcuSense shall use      reasonable endeavours to ensure that the quantities of Products set forth      in its Purchase Orders are consistent with the then-current      forecast. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (3) | A      Purchase Order constitutes an irrevocable offer made by OcuSense to      MiniFAB for the supply of the Products specified in the Purchase Order on      the terms and conditions of this Agreement. Once received by MiniFAB, the      Purchase Order is firm and may not be cancelled or modified without      MiniFAB's prior written consent. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (4) | Subject      to clauses 3.4(5) or 3.5, MiniFAB must accept a Purchase Order if the      quantity of the Product the subject of the Purchase Order is between 80%      and 150% of the most recent forecast. In addition, MiniFAB agrees to use      Commercially Reasonable Efforts to accept and satisfy Purchase Orders      exceeding 150% of the most recent forecast. In the event that OcuSense      places a Purchase Order that exceeds 150% of the most recent forecast,      MiniFAB shall (i) accept the Purchase Order with respect to quantities at      least equal to 150% of the most recent Purchase Order, and (ii) notify      OcuSense in writing of those quantities (if any) exceeding 150% of the      most recent forecast with respect to which MiniFAB is rejecting the      Purchase Order. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (5) | If      MiniFAB believes, on reasonable grounds, that a Purchaser Order is      materially incorrect or, to the extent a Purchase Order exceeds 150% of      forecast amounts, it is not capable of satisfying the Purchase Order with      respect to excess amounts so ordered, then MiniFAB may reject the Purchase      Order and must notify OcuSense as soon as possible. If MiniFAB does not      reject to a Purchaser Order within 5 Business Days of receipt of the      Purchase Order, then MiniFAB is deemed to have accepted the Purchaser      Order. Any rejection by MiniFAB of a Purchase Order that is not provided      for in this clause 3.4(5) or 3.5 is deemed to be a material breach of this      Agreement for the purposes of clause15.2(1). |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 3.5 | Annual Production      Capacity |
|--|-----|---------------------------------|

|  | (1) | Despite      clause 3.4(4), MiniFAB may, in its absolute discretion, refuse      to accept any Purchase Order for a particular Product if the Purchase      Order would require MiniFAB to exceed the Annual Production Capacity of      that Product during that year. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | (2) | The      parties may, from time to time, vary the Annual Production Capacity of a      particular Product by agreement in writing. If OcuSense requests MiniFAB      to increase the Annual Product Capacity, the parties shall promptly confer      and discuss such matter in good faith, and MiniFAB shall endeavor to      inform OcuSense within thirty (30) days whether MiniFAB will agree to the      requested increase in the Annual Production  Capacity. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 3.6 | Delivery |
|--|-----|----------|

|  | 3.7 | Inspection and Nonconforming      Goods |
|--|-----|-----------------------------------------|

|  | (1) | OcuSense      must inspect the Products within 14 days after delivery (or      such longer time as provided in the Technical Agreement) and must      accept the Products if they meet the Specifications, the requirements      of the Technical Agreement, and the Regulatory Requirements. If OcuSense      fails to object in writing within the applicable period, then OcuSense      must accept the delivered Products. OcuSense may reject the delivered      Products only if the Products fail to meet the Specifications, the      requirements of the Technical Agreement,and/or the Regulatory      Requirements. If OcuSense rejects the delivered Products, OcuSense must      provide MiniFAB in writing the reasons for the rejection and the      reasonably available evidence to substantiate those reasons. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | If OcuSense rejects the      relevant Product, then MiniFAB shall promptly supply conforming      replacement Products as soon as possible, whether or not MiniFAB agrees      that OcuSense properly rejected such Products. MiniFAB agrees to notify      OcuSense in writing if such replacement Products will not be shipped      within five (5) business days. |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | If      OcuSense properly rejected the original Products, then OcuSense's payment      for the rejected Products shall be deemed payment for the replacement      Products. If OcuSense was not entitled to reject the original Products,      then OcuSense shall pay for both the rejected Products and the replacement      Products. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | If      the parties disagree whether OcuSense properly rejected the original      Products, then the parties shall refer such matter to a mutually      acceptable, independent testing laboratory (the Testing Lab) to      determine whether such Products were properly rejected. The fees and costs      of the Testing Lab shall be borne by OcuSense if the Testing Lab      determines that the Products were improperly rejected and by MiniFAB if      the Testing Lab determines that the Products were properly rejected. If      the Testing Lab is unable to determine whether the rejected Products met      the Specifications, the requirements of the Technical Agreement or the      Regulatory Requirements, then either party may submit the matter to the      dispute resolution process in clause19. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (5) | OcuSense      may withhold payment for any rejected Products (and only the rejected      Products) until: |
|--|-----|----------------------------------------------------------------------------------------------------------------|

|  | (a) | MiniFAB      re-delivers conforming Products, or |
|--|-----|--------------------------------------------------|

|  | (b) | the      Testing Lab or dispute resolution process determines that      the Products rejected by OcuSense met the Specifications,      the requirements of the Technical Agreement and the      Regulatory Requirements. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 3.8 | Technical      Agreements |
|--|-----|---------------------------|

|  | 3.9 | Quality      Control |
|--|-----|----------------------|

|  | 4. | Price |
|--|----|-------|

|  | 4.2 | Price      revisions |
|--|-----|----------------------|

|  | (1) | When      the Minimum Orders requirement for the Second Product has      been satisfied, the parties will meet and discuss any revision to the      Price of the Second Product, with the intent that the price will be      adjusted as mutually agreed by the parties to  reflect: |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (a) | the      fact that the initial capital expenses incurred by MiniFAB have      been amortised; |
|--|-----|----------------------------------------------------------------------------------------------------|

|  | (b) | any      further capital expenses incurred by MiniFAB to meet expected demand;      and |
|--|-----|----------------------------------------------------------------------------------------------|

|  | (c) | any      cost savings and efficiency improvements (which will be      shared equally unless otherwise agreed between the      parties). |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | The      parties agree to act reasonably when negotiating the revision to the      Price of the SecondProduct. |
|--|-----|---------------------------------------------------------------------------------------------------------------------|

----

|  | 5. | Development      of New Products |
|--|----|----------------------------------|

|  | 5.1 | R&D Services |
|--|-----|------------------|

|   | (1) | R&D      Services for New Products include: |
|--------|-----|-------------------------------------------------|

|  | (a) | project      management services relating to the development of the      New Product; |
|--|-----|--------------------------------------------------------------------------------------------|

|  | (b) | assisting      OcuSense in the development, validation and finalisation of the      Requirement Definitions for the NewProduct; |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------|

|  | (c) | assisting      OcuSense in the development, validation and finalisation of the      Specifications for the New Product; |
|--|-----|------------------------------------------------------------------------------------------------------------------------------|

|  | (d) | using      Commercially Reasonable Efforts to develop processes, methodology and      technology to manufacture the New Product; |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------|

|  | (e) | using      Commercially Reasonable Efforts to evaluate and recommend appropriate      technology necessary to manufacture the New  Product; |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------|

|  | (f) | using      Commercially Reasonable Efforts to develop and construct plant and      equipment necessary to manufacture the New Product;  and |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (g) | such      other services as specified in a Development  Order. |
|--|-----|----------------------------------------------------------------|

|  | (2) | R&D      Services exclude: |
|--|-----|--------------------------------|

|  | (a) | the      initial formulation of and research on the Requirement      Definitions for the NewProduct; |
|--|-----|-----------------------------------------------------------------------------------------------------------|

|  | (b) | carrying      out experiments, clinical tests or other validation methodologies in      relation to the New Product; |
|--|-----|---------------------------------------------------------------------------------------------------------------------------|

|  | (c) | preparations      or filings relating to obtaining Registration for the      New Product; |
|--|-----|------------------------------------------------------------------------------------------------|

|  | (d) | sales,      distribution, marketing or public release of the New    Product; |
|--|-----|------------------------------------------------------------------------------|

|  | (e) | patent      review; and |
|--|-----|-------------------------|

|  | (f) | legal      or other professional advisoryservices. |
|--|-----|----------------------------------------------------|

|  | 5.2 | Request for      development |
|--|-----|------------------------------|

|  | (1) | OcuSense      may, from time to time, request MiniFAB in writing to provide      R&D Services to develop a New Product (Development      Request). |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (2) | Subject      to clause 5.2(4), if and when OcuSense elects, in its discretion,      to develop a Second Product, OcuSense agrees that it will provide an      opportunity for MiniFAB to provide the R&D Services with respect to      the Second Product, as follows: |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (a) | OcuSense      shall provide a written Development Request for the Second Product      pursuant to clauses 5.2(1) and5.2(3); |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------|

|  | (b) | the      parties shall discuss in good faith the anticipated activities      under the Development Request and capabilities required to perform      such activities; |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (c) | if      MiniFAB does not wish to undertake to perform the applicable R&D      Services for the Second Product, MiniFAB agrees to promptly notify      OcuSense in writing; |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (d) | if      MiniFAB wishes to perform the applicable R&D Activities for the Second      Product, MiniFAB shall propose the financial terms under which it is      willing to undertake the R&D Services specified in the Development      Request; and |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (e) | if      MiniFAB has appropriate capability to perform such R&D Activities for      the Second Product as set forth in the Development Request, and offers to      perform such activities on financial terms that are at least as favorable      to OcuSense as other bids for conducting such R&D Services OcuSense      receives from third parties with capability of performing such R&D      Services, then OcuSense shall engage MiniFAB for the conduct of such      R&D Services for the Second Product. In such event, the parties shall      prepare and sign a mutually agreed written Development Order, which shall      set forth the activities to be conducted, timelines, deliverables,      financial terms, and other mutually agreed terms and conditions regarding      such R&D Services. Such Development Order shall be consistent with the      intellectual property provisions and other applicable terms and conditions      of this Agreement. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | A      Development Request must include: |
|--|-----|------------------------------------------|

|  | (a) | a      detailed description of the NewProduct; |
|--|-----|------------------------------------------------|

|  | (b) | draft      Requirement Definitions for the New Product;and |
|--|-----|------------------------------------------------------------|

|  | (c) | a      draft project plan including a proposed  timetable. |
|--|-----|------------------------------------------------------------|

|  | (4) | MiniFAB      will consider a Development Request and notify OcuSense in      writing whether or not MiniFAB accepts the Development Request within      20 Business Days of receipt of the request. If MiniFAB fails to respond      within that time period, then it is deemed to have rejected the      Development Request. To avoid doubt, MiniFAB is not required to provide      any reason for rejecting a Development Request. It is understood that the      Development Request is intended as an opportunity for the parties to      negotiate terms and conditions on which MiniFAB may conduct the applicable      R&D Services for OcuSense. Accordingly, (i) MiniFAB shall not be      obligated to accept any Development Request, and (ii) except as expressly      set forth in clause 5.2(2)(e) with respect to the Second Product, OcuSense      shall not be obligated to engage MiniFAB to conduct R&D Services.      Without limiting the foregoing, if MiniFAB rejects (or is deemed to have      rejected) the Development Request for the Second Product, then despite      clause 5.2(2), OcuSense may engage another service provider to provide      R&D Services in respect of that Development Request. OcuSense shall      have no obligation to offer to MiniFAB any further opportunity, or to      engage MiniFAB, to perform any R&D Services except as expressly set      forth under clause 5.2(2). |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 5.3 | Development      Order |
|--|-----|------------------------|

|   | (1) | If      MiniFAB accepts a Development Request,then: |
|--------|-----|-----------------------------------------------------|

|  | (a) | MiniFAB      will provide OcuSense with a revised draft project plan. including      proposed milestones and payment milestones;and |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------|

|  | (b) | the      parties must meet within 20 Business Days of the acceptance to meet and      discuss the Development Request with the intent to finalise a Development      Order. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The      parties will act reasonably in negotiating the terms of the      Development Order. |
|--------|-----|---------------------------------------------------------------------------------------------------|

|   | (3) | To      avoid doubt, neither party is bound by a Development Request,      a Development Order or any obligations to develop a New Product until      the relevant Development Order is signed by both    parties. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.4 | Provision of R&D      Services |
|--|-----|------------------------------------|

|   | (1) | MiniFAB      will provide the R&D Services in accordance with the      relevant Development Order in a diligent and ethical manner, with due      care and skill and to a high professional standard, in accordance with      this Agreement, and all applicable Regulatory  Requirements. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | MiniFAB      will use Commercially Reasonable Efforts to meet any milestones agreed in      the relevant Development Order. Each Development Order may specify the      agreed-upon remedies that shall apply for any failure by MiniFAB to meet      such milestones, or otherwise fail to perform the R&D Services in      accordance with clause 5.4(1). |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 5.5 | Responsibilities of each      party |
|--|-----|-------------------------------------|

|   | (1) | MiniFAB      is responsible for and will bear the costs and expenses      associated with: |
|--------|-----|-------------------------------------------------------------------------------------------------|

|  | (a) | the      provision of the R&D Services in accordance with the relevant      Development Order (Development Expenses);      and |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------|

|  | (b) | the      construction and acquisition of any plant and equipment and other related      capital expenditures relating to the R&D  Services. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | OcuSense      will develop, validate and finalise the Requirement Definitions and the      Specifications of the New Product in consultation with MiniFAB. MiniFAB      will assist OcuSense in accordance with the R&D    Services. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | OcuSense      is solely responsible for and will bear all costs and      expenses associated with all activities relating to the research and      development of the New Product that are not expressly included as      part of R&D Services or that are expressly excluded from the      R&D Services. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 5.6 | Ownership of Requirement      Definitions andSpecifications |
|--|-----|-------------------------------------------------------------|

|  | 5.7 | Payment for R&D      Services |
|--|-----|-----------------------------------|

|  | 5.8 | Other matters relating to      Development Order |
|--|-----|--------------------------------------------------|

|  | (1) | the      Price for the New Product (provided that the Price for the Second      Product is set in accordance with clause  4.1(2)); |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | the      percentage applicable to calculating the amount payable under clause      3.3(8)(c) |
|--|-----|---------------------------------------------------------------------------------------------------|

|  | (3) | the      Minimum Orders requirement for the New Product, if any (provided      that the Minimum Order for the Second Product is set in accordance      with clause 3.3(7)(c)); and |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | the      Annual Production Capacity for the NewProduct. |
|--|-----|---------------------------------------------------------|

|  | 5.9 | Prototype      Acceptance Testing |
|--|-----|-----------------------------------|

|   | (1) | If      required under the relevant Development Order, the parties will      conduct acceptance testing of the New Product in accordance with this      clause 5.9. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | Promptly      upon completion of the development of the New Product, MiniFAB shall      manufacture and supply to OcuSense a reasonable number of prototype units      for the purposes of OcuSense's testing and evaluation, together with such      documentation (including without limitation the QA test report), materials      and equipment reasonably necessary for OcuSense to perform testing and      evaluation of the prototype. It is understood that the mutually agreed      Development Order may provide for the supply and testing of multiple sets      of prototype units for the New Product at different stages of development      (such as, for example, alpha prototypes and beta    prototypes). |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (3) | OcuSense      may reject the prototype of the New Product only if it does not conform to      the Requirement Definitions. OcuSense must accept the prototype of the New      Product if it conforms to the Requirement  Definitions. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (4) | If      OcuSense rejects the prototype then OcuSense must notify MiniFAB of the      reasons for such rejection and MiniFAB will have thirty (30) days to cure      such defect or non-conformance or dispute Ocusense's rejection pursuant to      the dispute resolution process under clause 19. OcuSense may require      MiniFAB to resubmit revised prototype units to OcuSense for testing and      evaluation until the prototype fully conforms to the Requirement      Definitions of the Product. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (5) | Upon      OcuSense's acceptance of the New Product (“Acceptance”),      OcuSense shall promptly inform MiniFAB in  writing. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 5.10 | Successful      Completion |
|--|------|----------------------------|

|  | (1) | if      the relevant Development Order provides a definition - the      meaning ascribed to that term in the Development Order;      or |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | the      Acceptance of a New Product by OcuSense, as such term is defined      in clause 5.9. |
|--|-----|----------------------------------------------------------------------------------------------------|

|   | 5.11 | Discontinuance - Unable to      finalise RequirementDefinitions |
|--------|------|-----------------------------------------------------------------|

|   | 5.12 | Discontinuance -      OcuSense |
|--------|------|--------------------------------|

|   | 6. | OcuSense      Licence |
|--------|----|-----------------------|

|   | 6.1 | Limited      licence |
|--------|-----|----------------------|

|  | (1) | Subject      to the terms and conditions of this Agreement, OcuSense grants      to MiniFAB during the Term a limited, royalty free, non-exclusive      licence (without the right to sublicense) under any Intellectual Property,      know-how and technical information owned (or licensed with the right to      sublicense) by OcuSense relating to the development or manufacture of the      Products (OcuSense      IP) to use OcuSense IP to perform MiniFAB's obligations under this      Agreement (OcuSense      Licence). |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | MiniFAB      may only use OcuSense IP to the extent necessary or desirable      to develop and manufacture the Products and New Products or      otherwise necessary for the purposes of this    Agreement. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | 6.2 | Provision of OcuSense IP    materials |
|--|-----|--------------------------------------------|

|   | 6.3 | Ownership of OcuSense IP and Improvements to      OcuSense IP |
|--------|-----|-------------------------------------------------------------------------|

|   | 6.4 | IP Warranties and      indemnity |
|--------|-----|----------------------------------|

|  | (1) | OcuSense      warrants that OcuSense has the right and authority to grant MiniFAB      the OcuSense Licence. |
|--|-----|-------------------------------------------------------------------------------------------------------------------|

|  | (2) | OcuSense      shall indemnify and at all times holds harmless MiniFAB against any Losses      resulting from a third person's claim against MiniFAB alleging that the      use of OcuSense IP by MiniFAB constitutes an infringement of any      Intellectual Property of that third person; provided, however, that      OcuSense shall not be obligated to indemnify MiniFAB, and MiniFAB shall      indemnify and at all times hold harmless OcuSense against any such Losses      (i.e., Loses arising from third party claims of infringement), to the      extent the alleged infringement results from any modifications and      developments made to OcuSense IP by MiniFAB other than in accordance with      instructions contained in anySpecifications. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 6.5 | Termination of      licence |
|--|-----|-----------------------------|

|   | 6.6 | Infringement and protection of      OcuSense IP |
|--------|-----|------------------------------------------------------|

----

|   | 7. | Obligations      of MiniFAB |
|--------|----|-----------------------------|

|   | 7.1 | Cooperation with      OcuSense |
|--------|-----|--------------------------------|

|   | 7.2 | Regulatory      licences |
|--------|-----|--------------------------|

|   | 7.3 | Batch      records |
|--------|-----|--------------------|

|  | (1) | samples      of each batch of Products manufactured under this Agreement;      and |
|--|-----|------------------------------------------------------------------------------------|

|  | (2) | batch      production and quality controlrecords, |
|--|-----|---------------------------------------------------|

|   | 7.4 | Facility      Audits |
|--------|-----|----------------------|

|   | 8. | Meeting |
|--------|----|---------|

|   | 8.1 | During      the Term, the parties will endeavour to meet at least every 6 months to      discuss and review the state of the relationship between      them.  Each party must ensure that at least one of its senior      representatives attend each meeting. Any meeting may be      teleconferenced. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | 8.2 | Each      party will alternate to organise the meeting. The party responsible      for organising the meeting must prepare a formal agenda prior to the      meeting and organise formal minutes to be taken and distributed to all      attendees after the meeting takes place. Each party may provide its      suggest agenda items. The compulsory topics for the agenda are as      follows: |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (1) | review      of previous minutes; and |
|--|-----|--------------------------------------|

|  | (2) | progress      of any development andregistration. |
|--|-----|---------------------------------------------------|

|   | 9. | Payment      and invoicing |
|--------|----|----------------------------|

|   | 9.1 | Invoice |
|--------|-----|---------|

|  | (1) | In      relation to the supply of Products, MiniFAB will invoice OcuSense on      a monthly in arrears basis. |
|--|-----|--------------------------------------------------------------------------------------------------------------------|

|  | (2) | In      relation to the provision of R&D Services, MiniFAB will invoice      OcuSense in accordance with the Development Agreement for the First      Product and the payment milestone specified in the relevant Development      Order for New Products. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 9.2 | Payment |
|--------|-----|---------|

|   | 9.3 | Interest |
|--------|-----|----------|

|   | 10. | Amendments      to Specifications |
|--------|-----|-----------------------------------|

|   | 10.1 | Compliance with Regulatory      Requirements |
|--------|------|----------------------------------------------|

|  | 10.2 | Voluntary      changes |
|--|------|------------------------|

|  | 10.3 | Cost of amendments to      Specifications or changes in Regulatory  Requirements |
|--|------|----------------------------------------------------------------------------------|

----

|   | 11. | Registrations,      safety and Product liability |
|--------|-----|--------------------------------------------------|

|   | 11.1 | Registrations of      Products |
|--------|------|--------------------------------|

|  | (1) | obtaining      all necessary Registrations for the Products;  and |
|--|-----|-------------------------------------------------------------------|

|  | (2) | maintaining      records of all sales of Product sufficient to adequately administer a      recall, market withdrawal or correction for such period as is required      under applicable regulations. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 11.2 | Adverse      events |
|--|------|---------------------|

|  | 11.3 | Notification of      defects |
|--|------|------------------------------|

|  | 11.4 | Recalls |
|--|------|---------|

|  | (1) | The      parties each must notify the other promptly and in writing if any Product      is requested or required to be the subject of a recall, market      withdrawal or correction (Recall). |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | OcuSense      is solely responsible for the handling and disposition of any      Recall and will assume all regulatory responsibility for such      matters, including responsibility for all communications with the      relevant Governmental Agencies. MiniFAB shall diligently cooperate      with OcuSense in the administration of any  recall. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (3) | If      a Recall is due to a non compliance with the Specifications or      the Regulatory Requirements of the Product that is caused by the      fault MiniFAB then MiniFAB will bear the reasonable cost of the      Recall. In all other cases OcuSense is solely responsible for the      cost of the Recall. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 12. | Insurance |
|--|-----|-----------|

|  | 12.1 | Required Insurance from      MiniFAB |
|--|------|--------------------------------------|

|  | (1) | all      insurances required by law, including workers compensation insurance in      accordance      with relevant law; and |
|--|-----|------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | public      liability insurance for an amount of not less than A$5 Million per claim      and      in the aggregate. |
|--|-----|----------------------------------------------------------------------------------------------------------------------|

|  | 12.2 | Required Insurance from      OcuSense |
|--|------|---------------------------------------|

|   | (1) | all      insurances required by law, including workers compensation insurance      in accordance with relevant law;and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------|

|   | (2) | product      liability insurance for an amount of not less than US$5 Million      per claim in the aggregate. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------|

|  | 12.3 | Evidence of      insurance |
|--|------|----------------------------|

|  | 13. | Warranties |
|--|-----|------------|

|  | 13.1 | Product      warranties |
|--|------|-------------------------|

|  | 14. | Third      party licensors and contractors; Technology  Transfer |
|--|-----|------------------------------------------------------------------|

|  | 14.1 | Sub-Contractors |
|--|------|-----------------|

----

|  | 14.2 | Cooperation with      Sensortec |
|--|------|---------------------------------|

|  | 14.3 | Non exclusive      arrangement |
|--|------|--------------------------------|

|  | 14.4 | Evaluation and licensing of      other third party technology |
|--|------|---------------------------------------------------------------|

|  | 14.5 | Technology Ownership and      Licensing; TechnologyTransfer |
|--|------|-------------------------------------------------------------|

|  | (1) | OcuSense      shall retain ownership of any pre-existing intellectual property rights in      materials and information provided by OcuSense to MiniFAB for use by      MiniFAB for the purposes of undertaking activities under this Agreement.      MiniFAB shall retain ownership of any pre-existing intellectual property      rights in materials, information, tools and methodologies provided by      MiniFAB for the purposes of undertaking activities under this Agreement      (and any improvements to them, except to the extent that those      improvements comprise patented or unpatented intellectual property owned      or controlled by OcuSense or that have application in the field of      measuring osmolarity or osmolality of, or other characteristic of or any      biomarker in, human tear fluid) (collectively, "MiniFAB Background IP")      and MiniFAB hereby grants OcuSense a worldwide, non-exclusive,      royalty-free license (with the right to grant and authorize sublicenses)      to make, have made, use, offer for sale, sell and otherwise exploit      MiniFAB Background IP as may be required to make, have made, use, offer      for sale, sell and otherwise exploit Licensed Products or incorporated      into processes or procedures for manufacturing or testing Licensed      Products. As used herein, "Licensed Product" means      any article, item, product, equipment, process, data, report or other      deliverable designed or developed in whole or part for OcuSense by MiniFAB      under the Development Agreement or this Agreement, whether or not such      development or design is completed or successfully meets intended      criteria, including without limitation the First Product, Second Product      and any other New Products developed in whole or part under the      Development Agreement or in R&D Services performed by MiniFAB under      this Agreement. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (2) | Subject      to clause 14.5(1) and the requirement for OcuSense to pay MiniFAB all      outstanding fees and charges due to MiniFAB, MiniFAB agrees to assign and      hereby assigns to OcuSense all right, title and interest in and to any      trade dress, trademarks and design registrations or design patents, and      any inventions, whether patentable or not, and any other discoveries,      trade secrets or know-how which: |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (a) | are      embodied in a Licensed Product; and |
|--|-----|----------------------------------------------|

|  | (b) | were      made, developed, conceived or first reduced to practice by or for MiniFAB      as a direct result of MiniFAB undertaking activities under the Development      Agreement or this Agreement |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | At      any time during the term of this Agreement, or in the event of      any termination of this Agreement, OcuSense shall have the right to      require MiniFAB: |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|    | (a) | to      provide all reasonable assistance as requested by OcuSense, including      without limitation transfer of technology, materials,information      and documentation, to enable OcuSense to manufacturethe      Products internally or to secure the production and supply of the Products      by a third party contractor (whether or not all or part of such      technology, materials, information and documentation falls within the      MiniFAB Background IP owned by MiniFAB);  and |
|--------------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|     | (b) | to      provide OcuSense with the consultancy services of all keyengineering      personnel of MiniFAB to effect or support such transfer oftechnology      and/or the license to MiniFAB Background      IP. |
|--------------------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | All      MiniFAB Background IP shall be treated by OcuSense and its sublicensees       and their third party manufacturers as Confidential Information of      MiniFAB;  provided, however, that (i) OcuSense may disclose the      MiniFAB Background  IP to actual and potential investors,      sublicensees, advisors and/or contract  manufacturers of Licensed      Products, in each case under reasonable and  customary terms of      confidentiality; and (ii) OcuSense and its sublicensees and  contract      manufacturers may disclose such information as is reasonably       necessary in seeking regulatory approvals in connection with the      manufacture,  clinical development, use or commercialization of      Licensed Products. For clarity, this clause 14.5(4) shall not be construed      to prevent the use of MiniFAB Background IP in under authority of the      license set forth in clause 14.5(1)above. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (5) | This      clause 14.5 will survive termination of this  Agreement. |
|--|-----|--------------------------------------------------------------------|

|  | 15. | Term,      breach and termination |
|--|-----|-----------------------------------|

|  | 15.1 | Term |
|--|------|------|

|  | (1) | This      Agreement commences on the Commencement Date and continues for an      initial period of ten (10) years after the Commencement    Date. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | This      Agreement shall automatically renew for additional terms of three      (3)years      each, unless either party provides the other party with a written notice      ofnon-renewal      at least 180 days prior to the scheduled expiration of the thencurrent      term. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 15.2 | Termination for      cause |
|--|------|----------------------------|

|  | (1) | the      Defaulting Party commits a material breach of this Agreement and fails to      correct the breach within 30 days after written notice to do      so; |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | the      Defaulting Party fails to carry out any material provision of this      Agreement and the failure is not capable of remedy;  and/or |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3)  | an      Insolvency Event occurs in relation to the Defaulting    Party. |
|--|-----------|-------------------------------------------------------------------------|

|  | 15.3 | Effect of      termination |
|--|------|----------------------------|

|  | (1) | Upon      termination or expiry of this Agreement for any reason other than      for material breach by MiniFAB or due to an Insolvency Event in      relation to OcuSense, MiniFAB will complete the delivery of all      outstanding Purchase Orders. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | Upon      termination of this Agreement for material breach by      MiniFAB, OcuSense may elect to cause MiniFAB to complete the delivery      of all outstanding Purchase Orders or to cancel any or all      outstanding Purchase Orders (in whole or in  part). |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | Upon      termination or expiry of this Agreement for any  reason |
|--|-----|-------------------------------------------------------------------|

|  | (a)  | OcuSense      must pay all outstanding undisputed invoices for allcompleted      Purchase Orders; |
|--|-----------|---------------------------------------------------------------------------------------------------|

|  | (b) | all      Development Orders are deemed to be discontinued  and: |
|--|-----|-----------------------------------------------------------------|

|  | (i) | if      this Agreement is terminated under clause 15.2 and MiniFAB is the      Defaulting Party, then MiniFAB will be responsible for      all Development Expenses incurred;and |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (ii) | if      this Agreement is terminated for any other reason, then OcuSense must      pay MiniFAB all Development Expenses incurred and any other      unavoidable costs incurred by MiniFAB in connection with the      termination, as set forth in clause 5.12;and |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (c) | each      party must immediately return the Confidential Information of      the other party to the otherparty. |
|--|-----|----------------------------------------------------------------------------------------------------------------------|

|  | (4) | Except      as provided in clause 15.4, termination is without prejudice to      the rights of either party for any prior  breach. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------|

|  | 15.4 | Termination      Fee |
|--|------|----------------------|

|  | (1) | If      this Agreement is terminated for any reason, other than where MiniFAB      is the Defaulting Party, and the Minimum Orders requirements set      forth in clause 3.3(7) have not been satisfied on or before the effective      date of termination (other than as a result of the inability or failure of      MiniFAB to timely supply conforming Products in quantities ordered by      OcuSense), then OcuSense shall be deemed to have failed to meet the      Minimum Orders requirement, and shall pay MiniFAB the amounts specified in      clause 3.3(8) (Termination Fee);      provided, however, the Termination Fee shall not include any amounts with      respect to Minimum Orders requirements for Second Products as set forth in      clause 3.3(7)(c) and 3.3(8)(c) unless such termination is effective after      the date MiniFAB notifies OcuSense pursuant to clause 3.2(2) that MiniFAB      has put in place the necessary plant and equipment to manufacture the      Second Product to meet the Minimum Orders of that  Product. |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | The      parties acknowledge and agree that (i) the Termination Fee is a genuine      pre-estimate of the anticipated loss or damage which would be suffered by      MiniFAB as a result of the early termination of this Agreement, (ii) the      agreed upon Termination Fee shall be in lieu of any actual or alleged      damages, losses or harm to MiniFAB resulting from such Termination and/or      from any failure of OcuSense to order or purchase Products from MiniFAB      under this Agreement (Termination Losses), and      (iii) MiniFAB waives its right to seek recovery or reimbursement of all      Termination Losses other than the Termination  Fee. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 15.5 | Survival |
|--|------|----------|

|  | 16.  | Liability      and indemnity |
|--|-----------|------------------------------|

|  | 16.1  | Indemnity by      OcuSense |
|--|------------|----------------------------|

|  | (1)  | any      grossly negligent, unlawful, fraudulent or wilful misconduct committed      byOcuSense      or its Representatives in the performance of this    Agreement; |
|--|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2)  | the      marketing, promotion, sale or supply of the Product by OcuSense;      or |
|--|-----------|-----------------------------------------------------------------------------------|

|  | (3) | OcuSense's failure      to obtain, maintain or comply in any respect with any Registrations, |
|--|-----|----------------------------------------------------------------------------------------------|

----

|  | 16.2 | Indemnity by      MiniFAB |
|--|------|---------------------------|

|  | (1) | any      grossly negligent, unlawful, fraudulent or wilful misconduct committed by      MiniFAB or its Representatives in the performance of this      Agreement; |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | any      manufacturing defect in any Product supplied by MiniFAB to OcuSense, or      any failure of any such Product to conform to the Specifications or the      Regulatory Requirements therefor;or |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | MiniFAB's      failure to obtain and maintain all necessary governmental permits for the      development and manufacture of Products  hereunder. |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 16.3 | General provisions applicable      to indemnities |
|--|------|---------------------------------------------------|

|  | 16.4 | No consequential      damages |
|--|------|-------------------------------|

----

|  | 17. | Goods      and services tax |
|--|-----|-----------------------------|

|  | 17.1 | In      this clause 17: |
|--|------|-------------------------|

|  | (1) | GST means GST as      defined in A New Tax System (Goods and Services Tax) Act      1999 as amended (GST      Act) or any replacement or other relevant legislation and      regulations; |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | words      or expressions used in this clause which have a particular meaning      inthe      GST      law (as defined in the GST Act, and also including any      applicablelegislative      determinations and Australian Taxation Office public rulings) havethe      same meaning, unless the context otherwise  requires; |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | any reference to GST payable      by a party includes any corresponding GST payable by the representative      member of any GST group of which that party is a  member; |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | any      reference to an input tax credit entitlement by a party includes      anycorresponding      input tax credit entitlement by the representative member of any GST group      of which that party is a member;and |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | if      the GST law treats part of a supply as a separate supply for the purpose      ofdetermining      whether GST is payable on that part of the supply or for thepurpose      of determining the tax period to which that part of the supply isattributable,      such part of the supply is to be treated as a separate      supply. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 17.2 | Unless      GST is expressly included, the consideration to be paid or provided under      any other clause of this Agreement for any supply made under or in      connection with this Agreement does not include  GST. |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 17.3 | To      the extent that any supply made under or in connection with this Agreement      is a taxable supply, the GST exclusive consideration otherwise to be paid      or provided for that taxable supply is increased by the amount of any GST      payable in respect of that taxable supply and that amount must be paid at      the same time and in the same manner as the GST exclusive consideration is      otherwise to be paid or provided. A party's right to payment under this      clause is subject to a valid tax invoice being delivered to the recipient      of the taxable supply. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 17.4 | To      the extent that one party is required to reimburse or indemnify another      party for aloss, cost or expense incurred by that other party, that loss,      cost or expense does notinclude any amount in respect of GST for which      that other party is entitled to claim aninput tax  credit. |
|--|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 18. | Confidentiality |
|--|-----|-----------------|

|  | 18.1 | Prohibited      acts |
|--|------|----------------------|

|  | (1) | to      the party's sub-contractors, employees, legal advisers, auditors,      investors or other consultants in order for this Agreement to be      performed, provided that the recipients of the information undertake in      writing to the party to keep that information strictly confidential;      or |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | to      Regulatory Authorities as required to obtain or maintain any      regulatory approvals. |
|--|-----|------------------------------------------------------------------------------------------------------|

----

|  | 18.2 | Permitted      uses |
|--|------|---------------------|

|  | 18.3 | Excluded      information |
|--|------|---------------------------|

|  | (1) | was      in the public domain when it was disclosed to the receiving      party; |
|--|-----|----------------------------------------------------------------------------------|

|  | (2) | becomes,      after being disclosed to the receiving party, part of the      public domain, except through disclosure contrary to this      Agreement; |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (3) | was      already in the receiving party's possession when it was disclosed to the      receiving party and was not otherwise acquired from the other party      directly or indirectly; or |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | was      lawfully disclosed to the receiving party by a third party having the      unrestricted legal right to disclose that information without requiring      the maintenance of confidentiality. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 18.4 | Compulsory      disclosures |
|--|------|-----------------------------|

|   | 18.5 | Protection of      information |
|--------|------|--------------------------------|

|   | 18.6 | Confidentiality of      agreement |
|--------|------|-----------------------------------|

----

|  | (1) | by      either party to its sub-contractors, employees, auditors,      consultants, professional advisers, bankers, financial advisers,      financiers, investors and potential investors upon those persons      undertaking to keep confidential any information so disclosed;      or |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | to      comply with any applicable law or requirement of any      Governmental Agency or of any public stock exchange on which shares      of the disclosing party arelisted. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 18.7 | Return of Confidential      Information |
|--|------|-----------------------------------------|

|  | 19. | Disputes |
|--|-----|----------|

|  | 19.1 | Attempt to      Settle |
|--|------|------------------------|

|  | 19.2 | Limitations on Court      Proceedings |
|--|------|---------------------------------------|

|  | 19.3 | Disputes relating to      Product |
|--|------|-----------------------------------|

|  | 19.4 | Other      disputes |
|--|------|---------------------|

|  | 19.5  | Arbitration |
|--|------------|-------------|

|  | (1) | If      any dispute arises under, or in connection with, this Agreement and/or any      Development      Order, or in connection with any breach or alleged breach of this      Agreement or any Development Order, and such matter is not resolved      pursuant to clause 19.1 or 19.3 or by other agreement of the parties, such      matter shall be finally resolved through binding arbitration as set forth      in this clause 19.5. Either party may initiate arbitration of such a      matter, and the party initiating arbitration of such dispute must give to      the other party or parties to the dispute notice specifying the dispute      and requiring its resolution under this clause 19.5 (Notice of Dispute). Such      Notice of Dispute shall be given in accordance with the arbitration rules      specified under this clause19.5. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (2) | Each      such dispute is by this clause 19.5 referred to binding arbitration for      final resolution. The arbitration must be conducted  in: |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (a) | Melbourne,      Australia if the Notice of Dispute is given by      OcuSense; and |
|--|-----|----------------------------------------------------------------------------------------|

|  | (b) | San      Diego California, USA, if the Notice of Dispute is given      by MiniFAB. |
|--|-----|----------------------------------------------------------------------------------------------|

|  | (3) | If      the parties have not agreed upon the arbitrator within 7 days after the      Notice of Dispute is given, the arbitrator is the person appointed by the      Chair of the Victorian Chapter of the Institute of Arbitrators and      Mediators Australia (Principal Appointor) or      the Principal Appointor's nominee, acting on the request of any party to      the dispute. |
|--|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (4) | The      arbitrator must not be a present or former member, officer, employee or      agent of a party to the dispute or a person who has acted as a mediator or      advised any party in connection with the  dispute. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (5) | The      arbitration shall be conducted in accordance with the then-current rules      of the International Centre for Dispute Resolution by one (1) arbitrator      appointed in accordance with such rules. The arbitrator shall determine      what discovery will be permitted, consistent with the goal of limiting the      cost and time which the parties must expend for discovery; provided the      arbitrator shall permit such discovery as the arbitrator deems necessary      to permit an equitable resolution of the dispute. The arbitrator shall not      order or require discovery against either party of a type or scope that is      not permitted against the other party. The costs of the arbitration,      including administrative and arbitrators' fees, shall be shared equally by      the parties, and each party shall bear its own costs and attorneys' and      witness' fees incurred in connection with the arbitration. Any arbitration      subject to this Article shall be completed within one (1) year from the      filing of notice of a request for such arbitration. No punitive damages      may be granted by the arbitrator. The arbitration proceedings and the      decision shall not be made public without the joint consent of the      parties, and each party shall maintain the confidentiality of such      proceedings and decision unless otherwise permitted by the other party,      except to the extent (and solely to the extent) either party is required      to disclose such information by applicable securities or other laws. The      parties agree that the decision shall be the sole, exclusive and binding      remedy between them regarding any and all disputes, controversies, claims      and counterclaims presented to the arbitrator. Any award may be entered in      a court of competent jurisdiction for a judicial recognition of the      decision and applicable orders of enforcement, and either party may apply      to any court of competent jurisdiction for appropriate temporary      injunctive relief pending resolution of any arbitration proceeding. The      arbitrator shall provide a written arbitration award setting forth the      arbitrator's findings on material questions of law and of fact, including      references to the evidence on which the findings of fact were based. Each      party may be represented by a qualified legal practitioner or other      representative. |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (6) | This      clause 19.5 applies even where the Agreement is otherwise void      or voidable. |
|--|-----|-------------------------------------------------------------------------------------------------|

----

|  | 19.6 | Continuing      Obligations |
|--|------|-----------------------------|

|  | 19.7 | Except      as specifically provided in this Agreement, the parties must continue      to perform their obligations under this Agreement despite the      existence of a dispute or any steps being taken under this clause      19. |
|--|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 20. | Force      Majeure |
|--|-----|--------------------|

|  | 20.1 | Party not      liable |
|--|------|-----------------------|

|  | 20.2 | Notice of Force      Majeure |
|--|------|------------------------------|

|  | (1) | give      the other party prompt notice of the Force Majeure with reasonably full      particulars and an estimate of the extent and duration of its delay in      performance, or inability to perform;and |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | use      all possible diligence to resume normal performance of the delayed      obligations as quickly as possible. |
|--|-----|----------------------------------------------------------------------------------------------------------------------|

|  | 20.3 | Termination in case of Force      Majeure |
|--|------|-------------------------------------------|

|  | 21. | Notices |
|--|-----|---------|

|  | 21.1 | A      notice or other communication connected with this Agreement (Notice) has      no legal effect unless it is inwriting. |
|--|------|-----------------------------------------------------------------------------------------------------------------------------------|

|  | 21.2 | In      addition to any other method of service provided by law, the Notice may      be: |
|--|------|------------------------------------------------------------------------------------------|

|  | (1) | sent      by prepaid post to the address of the addressee set out in this      Agreement or subsequentlynotified; |
|--|-----|------------------------------------------------------------------------------------------------------------------------|

|  | (2) | sent      by facsimile to the facsimile number of the  addressee; |
|--|-----|-------------------------------------------------------------------|

|  | (3) | sent      via email to the email address of the addressee;  or |
|--|-----|----------------------------------------------------------------|

|  | (4) | delivered      at the address of the addressee set out in this Agreement or subsequently      notified. |
|--|-----|---------------------------------------------------------------------------------------------------------|

|  | 21.3 | If      the Notice is sent or delivered in a manner provided by clause 21.2, it      must be treated as given to and received by the party to which it is      addressed: |
|--|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (1) | if      sent by facsimile or email, on the next Business Day at the place of      receipt, unless a transmission failure notice is received by the      sender; or |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | if      sent by post or otherwise, upon receipt by the  addressee. |
|--|-----|--------------------------------------------------------------------|

|  | 21.4 | Despite      clause 21.3(1): |
|--|------|------------------------------|

|  | (1) | a      facsimile is not treated as given or received unless at the end of      the transmission the sender's facsimile machine issues a report      confirming the transmission of the number of pages in the      Notice; |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|  | (2) | a      facsimile is not treated as given or received if it is not received in      full and in legible      form and the addressee notifies the sender of that fact by the close of      the      Business Day on which it would otherwise be treated as given and      received. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 22. | General |
|--|-----|---------|

|  | 22.1 | Further      assurance |
|--|------|------------------------|

|  | 22.2 | Entire      understanding |
|--|------|---------------------------|

|  | 22.3 | Variation |
|--|------|-----------|

|  | 22.4 | Waiver |
|--|------|--------|

|  | 22.5 | Costs and      outlays |
|--|------|------------------------|

|  | 22.6 | Governing law and      jurisdiction |
|--|------|-------------------------------------|

----

| /s/      Michael Wilkinson         | /s/      Erol Harvey |
|-----------------------------------------|---------------------------|
| Director/company      secretary         | Director                  |
|                                    |                      |
| Michael Wilkinson                  | Erol Harvey          |
| Name      of director/company secretary | Name      of director     |
| (BLOCK      LETTERS)                    | (BLOCK      LETTERS)      |

| /s/      Stephen Zmina | /s/      Eric Donsky                   |
|-----------------------------|---------------------------------------------|
| Signature      of witness   | Signature      of authorised representative |
|                        |                                        |
| Stephen Zmina          | ERIC DONSKY,      CEO                  |
| Name      of witness        | Name      of authorised representative      |
| (BLOCK      LETTERS)        | (BLOCK      LETTERS)                        |

----

----

|  | 1.  | Description of New      Product |
|--|----------|---------------------------------|

|   | 2. | Draft New Product Development      Requirements |
|--------|----|-------------------------------------------------|

|   | 3. | Estimated Development      Expenses |
|--------|----|-------------------------------------|

|   | 4. | Project    Plan |
|--------|----|-----------------|

|   | 5. | Development Milestones and      Payments (if not included in the Project  Plan) |
|--------|----|---------------------------------------------------------------------------------|

|   | 6. | Successful      Completion |
|--------|----|----------------------------|

|   | 7. | Other    terms |
|--------|----|----------------|

----

----